Search Results 51-60 of 16648 for villous atrophy
The purpose of this study is to evaluate the efficacy and safety of Lu AF82422 for the treatment of MSA. Participation eligibility. Participant eligibility ...
Mayo Clinic researchers study risk factors, predictors, diagnostic techniques and potential treatments for posterior cortical atrophy, Alzheimer's disease and ...
Biopsy-confirmed CD (intestinal histology showing villous atrophy). Positive for human leukocyte antigen (HLA)-DQ2 or HLA-DQ2/DQ8 - results will be obtained ...
By comparing the gene expression of motor neurons derived from iPSC cells of phenotypically discordant Spinal Muscular Atrophy (SMA) sibling pairs and ...
The purpose of this study is to evaluate the safety and tolerability of YA-101. Participation eligibility. Participant eligibility includes age, gender, type ...
About this study. To evaluate whether SSRI use is associated with increased survival time and slower disease progression among patients with MSA.
Multiple system atrophy (MSA) is a rare, rapidly progressive, and invariably fatal neurological condition characterized by autonomic failure, parkinsonism, and/ ...
Vaginal atrophy (atrophic vaginitis) is the thinning and inflammation of the vaginal walls and lower urinary tract due to a lack of estrogen. The condition ...
The primary objectives of the study are to assess the safety, tolerability and evidence of activity of multiple intravitreal (IVT) injections of APL-2 in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.